StockData
Phathom Pharmaceuticals, Inc. logo

Phathom Pharmaceuticals, Inc. (PHAT) income statement

PHATNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/30
$5.30−0.20 (-3.64%)

Close on Nov 18, 2026Market cap $430.85MP/E –Yield –

Phathom Pharmaceuticals, Inc. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
80.7%
Operating margin
-9.3%
Net margin
-30.2%
Return on equity, FY2025
64.0%

Financial strength

Current ratio
1.76
Debt to equity
-0.48
Debt to assets
48.0%
Cash to current liabilities
105.5%

Valuation

P/E ratio
–
Price to sales
1.57
Price to book
–
Dividend yield
–

See a number that looks wrong?